|
Market Closed -
Nasdaq
05:00:00 14/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 955.47 USD | +0.45% |
|
+5.65% | +23.79% |
| Market Cap | 95.88B 86.89B 80.36B 72.51B 137B 9,040B 141B 965B 383B 4,829B 360B 352B 15,329B | P/E 2026 * |
16.1x | P/E 2027 * | 15.4x |
|---|---|---|---|---|---|
| Enterprise Value | 88.71B 80.39B 74.36B 67.09B 126B 8,364B 131B 893B 354B 4,468B 333B 326B 14,183B | EV / Sales 2026 * |
4.71x | EV / Sales 2027 * | 4.13x |
| Free-Float |
72.57% | Yield 2026 * |
0.4% | Yield 2027 * | 0.42% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Tradegate
| RGO | Real-time | |
|
Boerse Muenchen
| RGO | Real-time | |
|
London S.E.
| 0R2M | Delayed | |
|
Xetra
| RGO | End-of-day quote | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +0.45% | ||
| 1 week | +5.65% | ||
| Current month | +2.97% | ||
| 1 month | +22.75% | ||
| 3 months | +18.92% | ||
| 6 months | +34.03% | ||
| Current year | +23.79% |
| 1 week | 898.29 |  | 981.55 |
| 1 month | 780.83 | | 991.73 |
| Current year | 591.52 | | 991.73 |
| 1 year | 591.52 | | 991.73 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
George Sing
BRD | Director/Board Member | 76 | 08/01/1988 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/11/26 | Exercice | SVP Controller | 11,828 | 0.0117% | ||
| 3/11/26 | Exercice | Director | 22,317 | 0.0221% | ||
| 3/11/26 | Don | Chief Technology Officer | -1,054 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.45% | +5.65% | +37.78% | +20.38% | 95.88B | |
| +1.26% | +6.61% | +40.79% | +136.32% | 1,286B | |
| +0.79% | +3.45% | +45.84% | +93.52% | 688B | |
| +0.20% | +1.28% | +26.97% | +113.70% | 521B | |
| -0.44% | +3.69% | +41.45% | +68.91% | 386B | |
| +0.55% | +0.70% | +59.02% | +44.62% | 364B | |
| -0.12% | +0.74% | +28.39% | +58.54% | 302B | |
| +0.37% | +0.37% | +3.33% | +37.27% | 287B | |
| -0.30% | +1.14% | +38.29% | +72.46% | 252B | |
| +0.08% | +0.71% | +34.44% | +124.95% | 208B | |
| Average | +0.28% | +2.43% | +35.63% | +77.07% | 439B | |
| Weighted average by Cap. | +0.54% | +3.31% | +37.70% | +94.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.81B 17.05B 15.77B 14.23B 26.81B 1,774B 27.76B 189B 75.12B 948B 70.61B 69.11B 3,008B | 20.17B 18.28B 16.9B 15.25B 28.74B 1,902B 29.75B 203B 80.52B 1,016B 75.68B 74.08B 3,224B |
| Net income | 6.43B 5.82B 5.39B 4.86B 9.16B 606B 9.48B 64.71B 25.66B 324B 24.12B 23.6B 1,027B | 6.56B 5.94B 5.5B 4.96B 9.35B 618B 9.68B 66.05B 26.19B 330B 24.62B 24.09B 1,049B |
| Net Debt | -7.17B -6.5B -6.01B -5.42B -10.22B -676B -10.58B -72.17B -28.62B -361B -26.9B -26.33B -1,146B | -12.52B -11.34B -10.49B -9.47B -17.84B -1,180B -18.47B -126B -49.98B -630B -46.97B -45.98B -2,001B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | US$955.47 | +0.45% | 1,165,717 |
| 12/11/26 | US$951.19 | -0.86% | 1,211,308 |
| 11/11/26 | US$959.41 | +4.73% | 1,233,521 |
| 10/11/26 | US$916.06 | -0.42% | 517,079 |
| 09/11/26 | US$919.96 | +1.73% | 856,756 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
